Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Horvatits

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Wiener Klinisches Magazin : Beilage Zur Wiener Klinischen Wochenschrift|April 15, 2020
[Acute liver failure]Karoline Rutter, Thomas Horvatits, Andreas Drolz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 15, 2016
Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosisThomas Horvatits, Andreas Drolz, Kevin Roedl, et al.
Annals of Hepatology|October 17, 2021
Improvement of renal function prior to liver transplantation is not associated with better long-term renal outcome or survivalThomas Horvatits, Peter Hübener, Marcel Touma, et al.
Zeitschrift Fur Gastroenterologie|June 7, 2019
[Proton pump inhibitors in patients with liver cirrhosis - a survey among hepatologists in Germany]Thomas Horvatits, Andreas Drolz, Malte Wehmeyer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 9, 2020
Hepatitis E seroprevalence and viremia rate in immunocompromised patients: a systematic review and meta-analysisGustav Buescher, Ann-Kathrin Ozga, Eva Lorenz, et al.
Annals of Intensive Care|December 6, 2015
Prognostic impact of ICG-PDR in patients with hypoxic hepatitisThomas Horvatits, Nikolaus Kneidinger, Andreas Drolz, et al.
Journal of Hepatology|May 7, 2014
Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosisThomas Horvatits, Andreas Drolz, Kevin Roedl, et al.
Trials|April 13, 2022
Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trialMalte H Wehmeyer, Thomas Horvatits, Anika Buchholz, et al.
Ebiomedicine|July 14, 2022
Microplastics detected in cirrhotic liver tissueThomas Horvatits, Matthias Tamminga, Beibei Liu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 18, 2017
Renal replacement therapy in critically ill liver cirrhotic patients-outcome and clinical implicationsKatharina Staufer, Kevin Roedl, Danijel Kivaranovic, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Wiener Klinisches Magazin : Beilage Zur Wiener Klinischen Wochenschrift|April 15, 2020
[Acute liver failure]Karoline Rutter, Thomas Horvatits, Andreas Drolz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 15, 2016
Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosisThomas Horvatits, Andreas Drolz, Kevin Roedl, et al.
Annals of Hepatology|October 17, 2021
Improvement of renal function prior to liver transplantation is not associated with better long-term renal outcome or survivalThomas Horvatits, Peter Hübener, Marcel Touma, et al.
Zeitschrift Fur Gastroenterologie|June 7, 2019
[Proton pump inhibitors in patients with liver cirrhosis - a survey among hepatologists in Germany]Thomas Horvatits, Andreas Drolz, Malte Wehmeyer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 9, 2020
Hepatitis E seroprevalence and viremia rate in immunocompromised patients: a systematic review and meta-analysisGustav Buescher, Ann-Kathrin Ozga, Eva Lorenz, et al.
Annals of Intensive Care|December 6, 2015
Prognostic impact of ICG-PDR in patients with hypoxic hepatitisThomas Horvatits, Nikolaus Kneidinger, Andreas Drolz, et al.
Journal of Hepatology|May 7, 2014
Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosisThomas Horvatits, Andreas Drolz, Kevin Roedl, et al.
Trials|April 13, 2022
Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trialMalte H Wehmeyer, Thomas Horvatits, Anika Buchholz, et al.
Ebiomedicine|July 14, 2022
Microplastics detected in cirrhotic liver tissueThomas Horvatits, Matthias Tamminga, Beibei Liu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 18, 2017
Renal replacement therapy in critically ill liver cirrhotic patients-outcome and clinical implicationsKatharina Staufer, Kevin Roedl, Danijel Kivaranovic, et al.
Pageof 6